Biotechnologieaktien – KI-Analyse & Ranglisten
Durchsuchen Sie alle Biotechnologieaktien mit KI-gestützter Analyse, MoonshotScores und Kurszielen.
Durchsuchen Sie alle Biotechnologieaktien mit KI-gestützter Analyse, MoonshotScores und Kurszielen.
Wer sind die Wettbewerber von ?
| Unternehmen | Kurs | Änderung | Marktkapitalisierung | AI Score |
|---|---|---|---|---|
| INCY Incyte Corporation | $128.39 | +0.92% | $26.0B | 99 |
| KRYS Krystal Biotech, Inc. | $337.02 | -1.84% | $9.94B | 99 |
| CPRX Catalyst Pharmaceuticals, Inc. | $31.49 | +0.00% | $3.85B | 99 |
| EXEL Exelixis, Inc. | $53.69 | -1.29% | $13.5B | 98 |
| LQDA Liquidia Corporation | $71.05 | -5.68% | $6.32B | 98 |
| HRMY Harmony Biosciences Holdings, Inc. | $38.27 | +0.52% | $2.22B | 98 |
| ETON Eton Pharmaceuticals, Inc. | $59.91 | -2.55% | $1.64B | 98 |
| UTHR United Therapeutics Corporation | $514.86 | -1.18% | $21.9B | 98 |
| VRTX Vertex Pharmaceuticals Incorporated | $540.26 | -2.14% | $137B | 98 |
| VCYT Veracyte, Inc. | $41.79 | -0.95% | $3.33B | 96 |
| HALO Halozyme Therapeutics, Inc. | $106.12 | -1.39% | $12.6B | 96 |
| TBPH Theravance Biopharma, Inc. | $16.95 | -0.24% | $878M | 95 |
| CRMD CorMedix Inc. | $8.18 | -0.58% | $642M | 95 |
| TECH Bio-Techne Corporation | $72.28 | -0.28% | $11.3B | 94 |
| LGND Ligand Pharmaceuticals Incorporated | $287.39 | -1.14% | $5.76B | 94 |
| INVA Innoviva, Inc. | $21.13 | +0.62% | $1.56B | 93 |
| VCEL Vericel Corporation | $42.11 | -3.35% | $2.16B | 93 |
| NBIX Neurocrine Biosciences, Inc. | $153.21 | +0.18% | $15.4B | 93 |
| ZVRA Zevra Therapeutics, Inc. | $11.89 | -1.98% | $703M | 93 |
| RIGL Rigel Pharmaceuticals, Inc. | $45.77 | +1.15% | $847M | 92 |
| ALNY Alnylam Pharmaceuticals, Inc. | $229.30 | -5.49% | $30.7B | 92 |
| ADMA ADMA Biologics, Inc. | $9.73 | -0.26% | $2.26B | 91 |
| REGN Regeneron Pharmaceuticals, Inc. | $837.21 | +1.28% | $86.3B | 90 |
| CORT Corcept Therapeutics Incorporated | $121.05 | +1.71% | $14.0B | 90 |
| MDXG MiMedx Group, Inc. | $4.30 | -3.37% | $627M | 90 |
| CAI Caris Life Sciences, Inc. | $24.58 | +8.00% | $6.95B | 89 |
| ACAD ACADIA Pharmaceuticals Inc. | $29.34 | +1.02% | $5.02B | 88 |
| ARQT Arcutis Biotherapeutics, Inc. | $25.35 | -4.20% | $3.17B | 88 |
| PTGX Protagonist Therapeutics, Inc. | $150.69 | -2.74% | $9.69B | 86 |
| QTTB Q32 Bio Inc. | $15.86 | +0.13% | $472M | 83 |
| ABUS Arbutus Biopharma Corporation | $4.77 | -4.22% | $942M | 82 |
| RLYB Rallybio Corporation | $16.60 | -2.35% | $88.1M | 81 |
| ELVN Enliven Therapeutics, Inc. | $58.92 | -0.79% | $4.21B | 79 |
| ICCC ImmuCell Corporation | $10.09 | -0.39% | $91.3M | 78 |
| ORMP Oramed Pharmaceuticals Inc. | $4.79 | +0.00% | $196M | 77 |
| ABCL AbCellera Biologics Inc. | $11.57 | -3.66% | $3.53B | 76 |
| ABVX Abivax S.A. | $116.43 | -1.49% | $8.55B | 76 |
| CGEN Compugen Ltd. | $2.65 | +8.61% | $251M | 76 |
| CLYM Climb Bio, Inc. | $17.02 | -1.85% | $975M | 76 |
| ORKA Oruka Therapeutics, Inc. | $104.86 | -4.40% | $6.32B | 75 |
| RPRX Royalty Pharma plc | $61.31 | +1.21% | $27.2B | 75 |
| BRRGF BerGenBio ASA | $97.09 | +0.00% | $9.49B | 74 |
| MBX MBX Biosciences | $66.35 | -3.00% | $3.16B | 74 |
| NAGE Niagen Bioscience Inc | $3.15 | -0.63% | $251M | 74 |
| MGTX MeiraGTx Holdings plc | $14.19 | -2.42% | $1.31B | 73 |
| GNFTF Genfit S.A. | $16.28 | -1.33% | $816M | 73 |
| LBRX LB Pharmaceuticals Inc | $47.23 | -3.49% | $1.35B | 73 |
| ADAPY Adaptimmune Therapeutics plc | $0.027 | +0.00% | $7.16M | 72 |
| ALBO Albireo Pharma, Inc. | $44.15 | +0.00% | $916M | 71 |
| CVAC CureVac N.V. | $4.66 | +0.00% | $1.05B | 71 |
KI-Score von Stock Expert AI · Kursdaten: FMP / Yahoo Finance